Synthesis, metabolite analysis, and in vivo evaluation of [11C]irinotecan as a novel positron emission tomography (PET) probe-Reference-Cited by-同舟云学术

Synthesis, metabolite analysis, and in vivo evaluation of [11C]irinotecan as a novel positron emission tomography (PET) probe

Published:2013-07 Issue:5 Volume:40 Page:651-657
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Kawamura Kazunori,Hashimoto Hiroki,Ogawa Masanao,Yui Joji,Wakizaka Hidekatsu,Yamasaki Tomoteru,Hatori Akiko,Xie Lin,Kumata Katushi,Fujinaga Masayuki,Zhang Ming-Rong

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference39 articles.

1. Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, a novel water-soluble derivative of camptothecin, against murine tumors;Kunimoto;Cancer Res,1987

2. Synthesis and antitumor activity of 20(S)-camptothecin derivatives: Carbamate-linked, water soluble prodrugs of 7-ethyl-10-hydroxycamptothecin;Sawada;Chem Pharm Bull,1991

3. Irinotecan (CPT-11): recent developments and future directions-colorectal cancer and beyond;Rothenberg;Oncologist,2001

4. Role of pharmacogenetics in irinotecan therapy;de Jong;Cancer Lett,2006

5. Management of advanced colorectal cancer: state of the art;Saunders;Br J Cancer,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel serotonin decorated molecularly imprinted polymer nanoparticles based on biodegradable materials; A potential self-targeted delivery system for Irinotecan;Reactive and Functional Polymers;2022-12

2. Radiopharmaceutical Discovery with 11CO2-Fixation Methods Inspired by Green Chemistry;Methods in Pharmacology and Toxicology;2021-12-14

3. [11C]phosgene: Synthesis and application for development of PET radiotracers;Nuclear Medicine and Biology;2021-01

4. Radiochemistry with Carbon‐11;Handbook of Radiopharmaceuticals;2020-12-21

5. Pharmacokinetic and Pharmacogenetic Markers of Irinotecan Toxicity;Current Medicinal Chemistry;2019-07-01